🇺🇸 FDA
Patent

US 7449192

Use of neurotoxin therapy for treatment of urologic and related disorders related to neurogenic bladder dysfunction

granted A61KA61K38/4893A61K9/0019

Quick answer

US patent 7449192 (Use of neurotoxin therapy for treatment of urologic and related disorders related to neurogenic bladder dysfunction) held by The Regents of the University of Colorado expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/4893, A61K9/0019, A61K9/0034